Want to join the conversation?
$RL said 1Q17 revenues of $1.6Bil were down 4% vs. 1Q16 on a reported and constant currency basis. This is in line with the guidance provided this past June of a mid-single digit revenue decline. The company said that foreign currency translation did not have a material impact on revenue growth. Adjusted GM, excluding items, was 61.1% in 1Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?